Poly(methyl methacrylate) Bone Cement Composite Can Be Refilled with Antibiotics after Implantation in Femur or Soft Tissue
Source abstract
Abstract
While periprosthetic joint infections (PJIs) result in a small percentage of patients following arthroplasties, they are challenging to treat if they spread into bone and soft tissue. Treatment involves delivering antibiotics using poly(methyl methacrylate) (PMMA) bone cement. However, antibiotic release is insufficient for prolonged infections. Previous work demonstrated efficacy of incorporating insoluble cyclodextrin (CD) microparticles into PMMA to improve antibiotic release and allow for post-implantation drug refilling to occur in a tissue-mimicking model. To simulate how antibiotic refilling may be possible in more physiologically relevant models, this work investigated development of bone and muscle refilling models. The bone refilling model involved embedding PMMA-CD into rabbit femur and administering antibiotic via intraosseous infusion. Muscle tissue refilling model involved implanting PMMA-CD beads in bovine muscle tissue and administering antibiotic via tissue injection. Duration of antimicrobial activity of refilled PMMA-CD was evaluated. PMMA-CD composite in bone and muscle tissue models was capable of being refilled with antibiotics and resulted in prolonged antimicrobial activity. PMMA-CD provided sustained and on-demand antimicrobial activity without removal of implant if infection develops. Intraosseous infusion appeared to be a viable technique to enable refilling of PMMA-CD after implantation in bone, reporting for the first time the ability to refill PMMA in bone.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Total Knee Arthroplasty Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, OH 44106, USA
Funding
National Institutes of Health · National Science Foundation
References (40)
Show source-provided references
1. Orthopedic Prosthetic Infections: Diagnosis and Orthopedic Salvage10.1055/s-0036-1580730 ↗
2. Techniques in Arthroplasty: Use of an articulated PMMA spacer in the infected total knee arthroplasty10.1016/S0883-5403(05)80105-6 ↗
3. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery10.1302/0301-620X.89B7.19148 ↗
4. Bistolfi, A., Massazza, G., Verne, E., Masse, A., Deledda, D., Ferraris, S., Miola, M., Galetto, F., and Crova, M. (2011). Antibiotic-loaded cement in orthopedic surgery: A review. ISRN Orthop., 2011.10.5402/2011/290851 ↗
5. Cyphert, E.L., Learn, G.D., Hurley, S.K., Lu, C.-Y., and von Recum, H.A. (2018). An additive to PMMA bone cement enables postimplantation drug refilling, broadens range of compatible antibiotics, and prolongs antimicrobial therapy. Adv. Healthc. Mater., 7.10.1002/adhm.201800812 ↗
6. Dissolvable antibiotic beads in treatment of periprosthetic joint infection and revision arthroplasty: The use of synthetic pure calcium sulfate (Stimulan®) impregnated with vancomycin & tobramycin
7. Diagnosis and treatment of vascular surgery related infection10.2174/1874120701509010250 ↗
8. Combination antibiotic PMMA composites provide sustained broad-spectrum antimicrobial activity and allow for post-implantation refilling10.1021/acs.biomac.9b01523 ↗
9. Treatment of infected hip arthroplasty10.2174/1874325001004010126 ↗
10. Antibiotic-loaded bone cement as prophylaxis in total joint replacement10.1111/os.12351 ↗
11. Local antibiotic therapy in osteomyelitis10.1055/s-0029-1214162 ↗
12. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery10.1093/jac/47.6.885 ↗
13. Antibiotic-loaded polymethylmethacrylate beads and spacers in treatment of orthopedic infections and the role of biofilm formation
14. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement10.2106/JBJS.E.01126 ↗
15. Backgrounds of antibiotic-loaded bone cement and prosthesis-related infection10.1016/S0142-9612(03)00554-4 ↗
16. Combination of modified mixing technique and low frequency ultrasound to control the elution profile of vancomycin-loaded acrylic bone cement10.1302/2046-3758.52.2000412 ↗
17. Use of regional administration of prophylactic antibiotics in total knee arthroplasty10.1111/ans.14816 ↗
18. Comparison of antibiotic beads and intravenous antibiotics in open fractures10.1097/00003086-200003000-00028 ↗
19. Intraosseous and intravenous administration of antibiotics yields comparable plasma concentrations during experimental septic shock10.1111/aas.12454 ↗
20. Intraosseous infusion in elective and emergency pediatric anesthesia: When should we use it?10.1097/ACO.0000000000000069 ↗
21. Intraosseous infusion as a bridge to definitive access10.1177/000313481608201003 ↗
22. Affinity-based drug delivery10.1002/mabi.201000206 ↗
23. Cyclodextrin complexation for affinity-based antibiotic delivery10.1002/mabi.200900204 ↗
24. Rivera-Delgado, E., Xin, A., and von Recum, H.A. (2019). Using QSAR for predictions in drug delivery. BioRxiv.10.1101/727172 ↗
25. Antibiotic-releasing microspheres prevent mesh infection in vivo10.1016/j.jss.2016.06.099 ↗
26. Antibiotic Refilling, Antimicrobial Activity, and Mechanical Strength of PMMA Bone Cement Composites Critically Depend on Processing Technique10.1021/acsbiomaterials.0c00305 ↗
27. Bone defect animal models for testing efficacy of bone substitute biomaterials
28. Adhesion of Staphylococcus to orthopaedic metals, an in vivo study10.1016/S0736-0266(03)00152-9 ↗
29. Affinity interactions drive post-implantation drug filling, even in the presence of bacterial biofilm10.1016/j.actbio.2017.04.015 ↗
30. Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention10.1016/j.heliyon.2018.e01067 ↗
31. Implantable antimicrobial biomaterials for local drug delivery in bone infection models10.1016/j.actbio.2019.01.015 ↗
32. Implant infections: Adhesion, biofilm formation and immune evasion10.1038/s41579-018-0019-y ↗
33. Two-stage revision arthroplasty for the treatment of prosthetic joint infection10.1007/s12178-018-9495-y ↗
34. Two-stage revision after total knee arthroplasty
35. Periprosthetic joint infection: Current concepts and outlook10.1302/2058-5241.4.180092 ↗
36. Diagnosis of bone and joint infections10.1016/j.mporth.2019.03.001 ↗
37. Zimmerli, W. (2010). Chapter 52: Bone and joint infections. Antibiotic and Chemotherapy, Saunders. [9th ed.].10.1016/B978-0-7020-4064-1.00052-X ↗
38. Effect of material characteristics and/or surface topography on biofilm development10.1111/j.1600-0501.2006.01353.x ↗
39. Influence of surface roughness on the initial formation of biofilm10.1016/j.surfcoat.2015.07.062 ↗
40. Chatterjee, S., Biswas, N., Datta, A., and Maiti, P. (2019). Periodicities in the roughness and biofilm growth on glass substrate with etching time: Hydrofluoric acid etchant. PLoS ONE, 14.10.1371/journal.pone.0214192 ↗